Stock analysts at StockNews.com assumed coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research note issued to investors on Thursday. The brokerage set a "buy" rating on the stock.

LifeVantage Price Performance

LifeVantage stock opened at $3.80 on Thursday. The firm has a market capitalization of $47.76 million, a PE ratio of 95.00 and a beta of 1.12. The company's 50-day moving average is $3.82 and its 200-day moving average is $4.04. LifeVantage has a fifty-two week low of $3.46 and a fifty-two week high of $7.07.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. increased its stake in shares of LifeVantage by 30.4% during the 1st quarter. Victory Capital Management Inc. now owns 13,868 shares of the company's stock worth $66,000 after purchasing an additional 3,235 shares during the last quarter. State Street Corp grew its stake in LifeVantage by 7.6% in the 1st quarter. State Street Corp now owns 46,191 shares of the company's stock valued at $220,000 after buying an additional 3,281 shares during the last quarter. Renaissance Technologies LLC grew its stake in LifeVantage by 0.3% in the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company's stock valued at $4,238,000 after buying an additional 3,300 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in LifeVantage by 117.5% in the 3rd quarter. Tower Research Capital LLC TRC now owns 11,362 shares of the company's stock valued at $42,000 after buying an additional 6,138 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC grew its stake in LifeVantage by 61.8% in the 2nd quarter. O Shaughnessy Asset Management LLC now owns 24,368 shares of the company's stock valued at $106,000 after buying an additional 9,312 shares during the last quarter. 27.06% of the stock is currently owned by institutional investors and hedge funds.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive and immune system function; a line of weight management products under the PhysIQ brand; IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Featured Stories

• Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
• MarketBeat: Week in Review 12/05 – 12/09
• There Is Fundamental Value In Broadcom, And It Yields 3.35%
• Costco vs Amazon: an end of the year showdown
• Discount Retailers Could Make Good Bargain Stocks
• Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.